MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
Abstract Background Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell ly...
| 出版年: | Cancer Cell International |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2017-06-01
|
| 主題: | |
| オンライン・アクセス: | http://link.springer.com/article/10.1186/s12935-017-0431-9 |
